Demannose

Demannose

SCHEMBL5070598

O=C[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.55
▸ PDE4A P27815 1/20 0.46
▸ AKR1B1 P15121 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ SLCO1B1 Q9Y6L6 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.41
▸ MPI P34949 1/20 0.35
▸ CYP2C19 P33261 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ TOP1 P11387 1/20 0.33
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demannose SCHEMBL9576995 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL1277 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL284703 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL94289 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL20956808 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL20500378 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL12474438 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL17144009 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Galactose SCHEMBL20818999 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1
Galactose SCHEMBL8371122 1.00 LMNA (0.58) LMNAL3MBTL1TDP1PDE4AAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3164138-B1 TREATMENT OF URINARY TRACT INFECTION BIOMEDICALS SWEDEN AB (SE) 2021-05-05 — — EP claimed
US-5135852-A Measuring resonant frequency changes caused by deposition of polymeric complex on electrode; incubating microorganisms, acidification, precipitation E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-04 — — US claimed
EP-3472291-B1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS HENKEL AG & CO KGAA (DE) 2023-12-20 — — EP disclosed
EP-3472290-B1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS HENKEL AG & CO KGAA (DE) 2023-05-03 — — EP disclosed
CN-109963949-A Use the sequencing based on nano-pore of the voltage mode with heterozygosis pattern stimuli 豪夫迈·罗氏有限公司 2019-07-02 — — CN disclosed
EP-3502221-A1 DETERGENT COMPOSITION CONTAINING AMINE OXIDE AND SUGAR SURFACTANTS Henkel AG & Co. KGaA (DE) 2019-06-26 — — EP disclosed
CN-109844528-A For the integrated circuit of nano-pore sequencing and the multi-chip packaging of flow cell 豪夫迈·罗氏有限公司 2019-06-04 — — CN disclosed
EP-3472290-A1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS Henkel AG & Co. KGaA (DE) 2019-04-24 — — EP disclosed
EP-3472291-A1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS Henkel AG & Co. KGaA (DE) 2019-04-24 — — EP disclosed
CN-109416354-A Osmotic Imbalance Method for Bilayer Formation 豪夫迈·罗氏有限公司 2019-03-01 — — CN disclosed
WO-2017216216-A1 CONCENTRATED ISOTROPIC LIQUID DETERGENTS CONTAINING POLYMERS HENKEL AG & CO. KGAA (DE) 2017-12-21 — — WO disclosed
EP-1956929-A2 AN EDIBLE COMPOSITION DANISCO A/S (DK) 2008-08-20 — — EP disclosed
EP-1940348-A2 A COMPOSITION COMPRISING A COUPLED ENZYME SYSTEM DANISCO A/S (DK) 2008-07-09 — — EP disclosed
WO-2007045251-A2 A COMPOSITION COMPRISING A COUPLED ENZYME SYSTEM DANISCO A/S (DK) 2007-04-26 — — WO disclosed
WO-2007045252-A2 AN EDIBLE COMPOSITION DANISCO A/S (DK) 2007-04-26 — — WO disclosed
US-5109128-A Use of zerovalent platinum, palladium, rhodium or ruthenium on support; by-product inhibition UOP (US) 1992-04-28 — — US disclosed
Send feedback